Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Aug;41(2):624–630. doi: 10.1128/iai.41.2.624-630.1983

Immune (gamma) interferon production by a murine T cell lymphoma: requirements for macromolecular synthesis and lack of relationship with cell cycle.

M Sarzotti, S Landolfo, F Dianzani
PMCID: PMC264688  PMID: 6192085

Abstract

Macromolecular synthesis of immune interferon (IFN-gamma) by the L12-R4 T cell lymphoma, stimulated by phorbol myristic acetate, was studied by using reversible inhibitors of protein synthesis, puromycin and cycloheximide, and an irreversible inhibitor of RNA synthesis, actinomycin D. Reversible inhibition of protein synthesis during the first 3 h of stimulation had no effect on IFN-gamma production. The same treatment, performed 4 h after stimulation and maintained for an additional 5 h, decreased significantly the capability of L12-R4 cells to produce IFN-gamma. When the inhibitors of protein synthesis were left in the cultures, a complete block of IFN-gamma production was observed. Irreversible inhibitors of RNA synthesis at the beginning of stimulation did block IFN-gamma production by L12-R4 cells, but the same treatment was ineffective if performed 6 h after stimulation. These data suggest that continued protein synthesis is needed for IFN-gamma production, whereas the RNA seems to be completely synthesized within 4 to 6 h of stimulation. The relationship between IFN-gamma production and cell cycle phases was studied with the aid of a reversible drug, aphidicolin, that arrests cells at the G1/S border. Phorbol myristic acetate stimulation of L12-R4 cells after aphidicolin removal induced comparable levels of IFN-gamma at each different point of stimulation, indicating that IFN-gamma production by stimulated cells is not related to a particular phase but is continuously inducible during the cell cycle.

Full text

PDF
624

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dianzani F., Monahan T. M., Jordan C. A., Langford M. P. Inhibition of RNA synthesis in human lymphoid cells induces interferon production. Proc Soc Exp Biol Med. 1981 Jul;167(3):338–342. doi: 10.3181/00379727-167-41175. [DOI] [PubMed] [Google Scholar]
  2. Edy V. G., Billiau A., De Somer P. Enhancement of interferon production in mouse cell line, a high-yielding source of mouse interferon. Appl Microbiol. 1973 Sep;26(3):434–436. doi: 10.1128/am.26.3.434-436.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Garrick L. M., Garrick M. D. Testing with puromycin and amino acyl tRNAs that limit the rate of peptide chain extension. Mol Cell Biochem. 1978 Feb 24;19(1):49–59. doi: 10.1007/BF00231234. [DOI] [PubMed] [Google Scholar]
  4. Kasprisin D. O., Harris M. B. The role of protein synthesis in polymorphonuclear leukocyte phagocytosis II. Exp Hematol. 1978 Aug;6(7):585–589. [PubMed] [Google Scholar]
  5. Landolfo S., Arnold B., Suzan M. Immune (y) interferon production by murine T cell lymphomas. J Immunol. 1982 Jun;128(6):2807–2809. [PubMed] [Google Scholar]
  6. Milner J. Is protein synthesis necessary for the commitment of lymphocyte transformation? Nature. 1978 Apr 13;272(5654):628–629. doi: 10.1038/272628a0. [DOI] [PubMed] [Google Scholar]
  7. Mizel S. B., Mizel D. Purification to apparent homogeneity of murine interleukin 1. J Immunol. 1981 Mar;126(3):834–837. [PubMed] [Google Scholar]
  8. Nedrud J., Touton M., Clark W. R. The requirement for DNA synthesis and gene expression in the generation of cytotoxicity in vitro. J Exp Med. 1975 Oct 1;142(4):960–973. doi: 10.1084/jem.142.4.960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rubin B., Cooley M. A., Le Borgne de Kaouel C., Taylor R. B., Golstein P. Production and main characteristics of a fetal calf serum-specific cell line that induces T and B cell differentiation. Scand J Immunol. 1980;12(5):401–409. doi: 10.1111/j.1365-3083.1980.tb00084.x. [DOI] [PubMed] [Google Scholar]
  10. Stadler B. M., Dougherty S. F., Farrar J. J., Oppenheim J. J. Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines. J Immunol. 1981 Nov;127(5):1936–1940. [PubMed] [Google Scholar]
  11. Stewart W. E., 2nd, Lin L. S., Wiranowska-Stewart M., Cantell K. Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4200–4204. doi: 10.1073/pnas.74.10.4200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tovey M. G., Begon-Lours J., Gresser I. A method for the large scale production of potent interferon preparations. Proc Soc Exp Biol Med. 1974 Jul;146(3):809–815. doi: 10.3181/00379727-146-38196. [DOI] [PubMed] [Google Scholar]
  13. Unanue E. R., Kíely J. M. Synthesis and secretion of a mitogenic protein by macrophages: description of a superinduction phenomenon. J Immunol. 1977 Sep;119(3):925–931. [PubMed] [Google Scholar]
  14. Varesio L., Holden H. T. Mechanisms of lymphocyte activation: linkage between early protein synthesis and late lymphocyte proliferation. J Immunol. 1980 May;124(5):2288–2294. [PubMed] [Google Scholar]
  15. Varesio L., Holden H. T., Taramelli D. Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines. J Immunol. 1980 Dec;125(6):2810–2817. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES